Browse hierarchy: [Pathology (PA)](/submissions/PA) → [Subpart E — Specimen Preparation Reagents](/submissions/PA/subpart-e%E2%80%94specimen-preparation-reagents) → [21 CFR 864.4010](/submissions/PA/subpart-e%E2%80%94specimen-preparation-reagents/864.4010) → IFP — Formalin, Neutral Buffered # IFP · Formalin, Neutral Buffered _Pathology · 21 CFR 864.4010 · Class 1_ **Canonical URL:** https://fda.innolitics.com/submissions/PA/subpart-e%E2%80%94specimen-preparation-reagents/IFP ## Overview - **Product Code:** IFP - **Device Name:** Formalin, Neutral Buffered - **Regulation:** [21 CFR 864.4010](/submissions/PA/subpart-e%E2%80%94specimen-preparation-reagents/864.4010) - **Device Class:** 1 - **Review Panel:** [Pathology](/submissions/PA) - **GMP exempt:** yes ## Identification A general purpose reagent is a chemical reagent that has general laboratory application, that is used to collect, prepare, and examine specimens from the human body for diagnostic purposes, and that is not labeled or otherwise intended for a specific diagnostic application. It may be either an individual substance, or multiple substances reformulated, which, when combined with or used in conjunction with an appropriate analyte specific reagent (ASR) and other general purpose reagents, is part of a diagnostic test procedure or system constituting a finished in vitro diagnostic (IVD) test. General purpose reagents are appropriate for combining with one or more than one ASR in producing such systems and include labware or disposable constituents of tests; but they do not include laboratory machinery, automated or powered systems. General purpose reagents include cytological preservatives, decalcifying reagents, fixative and adhesives, tissue processing reagents, isotonic solutions and pH buffers. Reagents used in tests for more than one individual chemical substance or ligand are general purpose reagents (e.g., Thermus aquaticus (TAQ) polymerase, substrates for enzyme immunoassay (EIA)). ## Classification Rationale Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9. If the device is not labeled or otherwise represented as sterile, it is exempt from the current good manufacturing practice requirements of the quality management system regulation in part 820 of this chapter, except for requirements concerning records and complaint files under § 820.35 of this chapter. ## Recent Cleared Devices (15 of 15) | Record | Device Name | Applicant | Decision Date | Decision | | --- | --- | --- | --- | --- | | [K884755](https://fda.innolitics.com/submissions/PA/subpart-e%E2%80%94specimen-preparation-reagents/IFP/K884755.md) | CONSED FECAL CONCENTRATION SYSTEM | Donald L. Price, Ph.D. | Jan 10, 1989 | SESE | | [K872663](https://fda.innolitics.com/submissions/PA/subpart-e%E2%80%94specimen-preparation-reagents/IFP/K872663.md) | DRY-FORM | Anatech, Ltd. | Aug 6, 1987 | SESE | | [K872140](https://fda.innolitics.com/submissions/PA/subpart-e%E2%80%94specimen-preparation-reagents/IFP/K872140.md) | (MSI) PATH-SAVER | Medical Specialties, Inc. | Jun 15, 1987 | SESE | | [K870852](https://fda.innolitics.com/submissions/PA/subpart-e%E2%80%94specimen-preparation-reagents/IFP/K870852.md) | NBF 10% NEUTRAL BUFFERED FORMALIN | Anatech, Ltd. | Mar 31, 1987 | SESE | | [K853497](https://fda.innolitics.com/submissions/PA/subpart-e%E2%80%94specimen-preparation-reagents/IFP/K853497.md) | PREFILLED SPECIMEN JARS 10% NEUTRAL BUF-FORMALIN | Surgipath Medical Industries, Inc. | Aug 28, 1985 | SESE | | [K842982](https://fda.innolitics.com/submissions/PA/subpart-e%E2%80%94specimen-preparation-reagents/IFP/K842982.md) | FORMALIN BUFFERED | Reagent Laboratory, Inc. | Oct 1, 1984 | SESE | | [K842940](https://fda.innolitics.com/submissions/PA/subpart-e%E2%80%94specimen-preparation-reagents/IFP/K842940.md) | CBA FORMALIN | Anatech, Ltd. | Aug 28, 1984 | SESE | | [K842728](https://fda.innolitics.com/submissions/PA/subpart-e%E2%80%94specimen-preparation-reagents/IFP/K842728.md) | BUF-FIX | E K Ind., Inc. | Aug 3, 1984 | SESE | | [K840926](https://fda.innolitics.com/submissions/PA/subpart-e%E2%80%94specimen-preparation-reagents/IFP/K840926.md) | FORMALIN SOLUTION 10% NEUTRAL BUFFER | Sigma Chemical Co. | Mar 12, 1984 | SESE | | [K830583](https://fda.innolitics.com/submissions/PA/subpart-e%E2%80%94specimen-preparation-reagents/IFP/K830583.md) | NEUTRAL BUFFERED FORMALIN 10% | Surgipath Medical Industries, Inc. | Mar 17, 1983 | SESE | | [K830582](https://fda.innolitics.com/submissions/PA/subpart-e%E2%80%94specimen-preparation-reagents/IFP/K830582.md) | MILLONIG'S MODIFIED PHOSPHATE BUFFERED | Surgipath Medical Industries, Inc. | Mar 17, 1983 | SESE | | [K830514](https://fda.innolitics.com/submissions/PA/subpart-e%E2%80%94specimen-preparation-reagents/IFP/K830514.md) | MILLONIGS MODIFIED PHOSPHATE BUFFERED | Surgipath Medical Industries, Inc. | Mar 8, 1983 | SESE | | [K812940](https://fda.innolitics.com/submissions/PA/subpart-e%E2%80%94specimen-preparation-reagents/IFP/K812940.md) | 10% NEUTRAL BUFFERED FORMALIN CONCENT | Surgipath | Dec 10, 1981 | SESE | | [K812817](https://fda.innolitics.com/submissions/PA/subpart-e%E2%80%94specimen-preparation-reagents/IFP/K812817.md) | NEUTRAL DUFFERED FORMA-SCENT | Meridian Diagnostics, Inc. | Nov 10, 1981 | SESE | | [K811795](https://fda.innolitics.com/submissions/PA/subpart-e%E2%80%94specimen-preparation-reagents/IFP/K811795.md) | 10% NEUTRAL BUFFERED FORMALDEHYDE | Richard-Allan Medical Ind., Inc. | Jul 28, 1981 | SESE | ## Top Applicants - Surgipath Medical Industries, Inc. — 4 clearances - Anatech, Ltd. — 3 clearances - Surgipath — 1 clearance - Sigma Chemical Co. — 1 clearance - Richard-Allan Medical Ind., Inc. — 1 clearance --- **Source:** [https://fda.innolitics.com/submissions/PA/subpart-e%E2%80%94specimen-preparation-reagents/IFP](https://fda.innolitics.com/submissions/PA/subpart-e%E2%80%94specimen-preparation-reagents/IFP) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com